WithdrawnPhase 2NCT03867162
FY15-14: Tularemia Vaccine Protocol (NDBR Lot 4)
Studying Tularemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- U.S. Army Medical Research and Development Command
- Principal Investigator
- Benjamin C Pierson, MDUSAMRIID
- Intervention
- Live Attenuated Tularemia Vaccine(biological)
- Eligibility
- 18-65 years · All sexes
- Timeline
- 2021 – 2021
Study locations (1)
- Special Immunizations Program, Division of Medicine, USAMRIID, Fort Deterick, Maryland, United States
Collaborators
US Army Medical Research Institute of Infectious Diseases
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03867162 on ClinicalTrials.gov